HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor
Author:
Diana P. English,Dana M. Roque,Luisa Carrara,Salvatore Lopez,Stefania Bellone,Emiliano Cocco,Ileana Bortolomai,Peter E. Schwartz,Thomas Rutherford,Alessandro D. Santin
Publication:
Gynecologic Oncology
Copyright © 2013 Published by Elsevier Inc.